New analysis looks at bone drug risks vs. benefits

by | Sep 30, 2015 | Bone Drugs

bone drug risks versus benefits analysis

Wouldn’t it be valuable if there was one study to answer the important questions about bone drugs, including:

  • How effective are bisphosphonates?
  • How well do they actually work to prevent hip fractures?
  • What’s the possibility of harm from these bone drugs?

Now, there is one — thanks to researchers who conducted a detailed systematic analysis of clinical trials using bisphosphonate drugs to treat osteoporosis and prevent hip fractures.

Benefits vs. risks of bisphosphonates

Here are two striking numbers researchers discovered when looking at how bisphosphonates help or hurt the women who take them:

  • 175 postmenopausal women with bone fragility had to be treated for three years to prevent one single hip fracture.
  • Treating 300 people with bisphosphonate drugs for three years will result in one person being harmed from serious side effects.

What’s more, researchers noted that hip fracture rates in developed countries are declining, yet sales of bisphosphonate drugs tripled between 2001 in 2008 and are forecast to exceed $11 billion in 2015.

Also, while 80 is the average age at hip fracture, the evidence suggests no benefit from bisphosphonate bone drugs for this age group.

“Pharmacotherapy (for hip fracture prevention) can achieve at best a marginal reduction of hip fractures at the cost of unnecessary psychological harms, serious medical adverse events, and forgone opportunities to have greater impacts on the health of older people,” said Dr. Barbara Mintzes, one of the study authors.

I really appreciate that they took into account the psychological impacts of osteoporosis overdiagnosis, which is something I see often in my work.

Listen: The trouble with bisphosphonates

You can listen to Dr. Mintzes detail more about the research findings in the first 13 minutes of this interview that aired on Australian national radio titled “The trouble with bisphosphonates” here.

 

Reference:
Jarvinen, T.L., et al, Overdiagnosis of bone fragility in the quest to prevent hip fractures. BMJ 2015;350:h2088, 2015 May 26 (http://www.bmj.com/content/350/bmj.h2088)

Learn more about natural strategies in our guide to our natural approach to osteoporosis.

For natural support alongside any treatment, read our complete guide to bone health nutrition as a natural foundation.

Popular Posts

Why I’ve Been Testing My pH Since 1984 (And Why You Should Too)

Osteopenia Treatment – 9 Things You Should Do Today

Osteopenia Treatment – 9 Things You Should Do Today

Alkaline Meal Plan: 7-Day Plan to Cooking for Strong Bones

Alkaline Meal Plan: 7-Day Plan to Cooking for Strong Bones

FDA Rulings, Big Pharma, and the Bone Health Questions You Should Be Asking

FDA Rulings, Big Pharma, and the Bone Health Questions You Should Be Asking

Why Inflammation Keeps Returning to the Same Spot (And What It Means for Your Bones)

Why Inflammation Keeps Returning to the Same Spot (And What It Means for Your Bones)

No results found.
Dr. Susan E. Brown, PhD

Dr. Susan E. Brown, PhD

Dr. Susan E. Brown, PhD, is a medical anthropologist and New York State Certified Nutritionist with more than 40 years of experience in bone health research, clinical nutrition, and health education. She is the founder of the Center for Better Bones and the Better Bones Foundation, and author of Better Bones, Better Body — the first comprehensive guide to natural bone health. Her whole-body, alkaline-centered approach identifies 20+ nutrients essential for bone health and has helped thousands of women build stronger bones naturally. | Wikipedia: https://en.wikipedia.org/wiki/Susan_E._Brown | Amazon Author Page: https://www.amazon.com/Susan-E-Brown-PhD/e/B001HOFHX8/

Weekly wisdom from the woman who builds better bones

Pin It on Pinterest